Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Megaforce is a Taiwan-based, publicly listed manufacturing group (stock code 3294) providing contract design and manufacturing, primarily for high-precision plastics, electronics, and complex systems. It includes Megaforce MedTech, which focuses on design, development, and mass production of medical devices, and Megaforce Corporation in Silicon Valley, which offers electronics manufacturing services (NPI, PCB design/layout, PCBA, systems integration, testing, and supply-chain management) for markets including medical and biotechnology.[1][2][3][4][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Megaforce.